Literature DB >> 8245438

Production of soluble IL-4 receptors by murine spleen cells is regulated by T cell activation and IL-4.

P M Chilton1, R Fernandez-Botran.   

Abstract

Many cytokine receptors exist naturally as both membrane-bound and soluble forms. Whereas the membrane receptors have an obvious role in signal transduction, the putative immunoregulatory role played by the soluble receptors remains unclear. Although natural forms of soluble IL-4R (sIL-4R) are known to be present in the biologic fluids of normal mice, the mechanisms regulating the production of sIL-4R have not been characterized. In this study, we have developed an ELISA that allows the measurement of sIL-4R without interference from endogenous IL-4, and have analyzed the effect of cellular activation and several cytokines on the secretion of sIL-4R by murine splenic cells. Although normal spleen cells in culture produced low, but detectable levels of sIL-4R under basal conditions, stimulation with the T cell-mitogens, Con A or soluble anti-CD3 antibodies, caused a 10- to 40-fold increase in the production of sIL-4R. Stimulation of B lymphocytes with LPS, however, did not result in significant up-regulation of sIL-4R secretion. Moreover, IL-4, but not other cytokines, was also a potent inducer of sIL-4R production by spleen cells, even in the absence of other stimuli. Blocking experiments with an anti-IL-4 antibody, 11B11, demonstrated that the effect of T cell-mitogens is partially mediated by endogenously produced IL-4. Cell depletion experiments suggested that although the effect of T cell-mitogens was dependent on the presence of viable T cells, all major cell types including T cells, B cells, and macrophages, either resting or activated, were able to up-regulate their secretion of sIL-4R in response to IL-4. Unlike many activities of IL-4, the secretion of sIL-4R by IL-4-stimulated splenic cells was not antagonized by IFN-gamma. These results suggest that the production of sIL-4R is regulated by stimuli leading to T cell activation and IL-4 secretion and are consistent with sIL-4R having an important role in the regulation of IL-4 activity in vivo.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8245438

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

1.  Cytokines and soluble cytokine receptor induction after IL-12 administration in cancer patients.

Authors:  N Haicheur; B Escudier; T Dorval; S Negrier; P H De Mulder; J M Dupuy; D Novick; T Guillot; S Wolf; P Pouillart; W H Fridman; E Tartour
Journal:  Clin Exp Immunol       Date:  2000-01       Impact factor: 4.330

2.  Soluble Axl is generated by ADAM10-dependent cleavage and associates with Gas6 in mouse serum.

Authors:  Vadim Budagian; Elena Bulanova; Zane Orinska; Erwin Duitman; Katja Brandt; Andreas Ludwig; Dieter Hartmann; Greg Lemke; Paul Saftig; Silvia Bulfone-Paus
Journal:  Mol Cell Biol       Date:  2005-11       Impact factor: 4.272

3.  Follicular dendritic cells restrict interleukin-4 availability in germinal centers and foster memory B cell generation.

Authors:  Lihui Duan; Dan Liu; Hsin Chen; Michelle A Mintz; Marissa Y Chou; Dmitri I Kotov; Ying Xu; Jinping An; Brian J Laidlaw; Jason G Cyster
Journal:  Immunity       Date:  2021-09-22       Impact factor: 43.474

4.  Increased capacity for interleukin-2 synthesis parallels disease progression in mice infected with Leishmania major.

Authors:  F P Heinzel; R M Rerko; A M Hujer; R A Maier
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

5.  Modulation of cell-bound and soluble CD23, spontaneous and ongoing IgE synthesis of human peripheral blood mononuclear cells by soluble IL-4 receptors and the partial antagonistic IL-4 mutant protein IL-4 (Y124D).

Authors:  B König; A Fischer; W König
Journal:  Immunology       Date:  1995-08       Impact factor: 7.397

6.  Antibody responses against the vaccine antigens Ov-103 and Ov-RAL-2 are associated with protective immunity to Onchocerca volvulus infection in both mice and humans.

Authors:  Parakkal Jovvian George; Jessica A Hess; Sonia Jain; John B Patton; Tingting Zhan; Nancy Tricoche; Bin Zhan; Maria Elena Bottazzi; Peter J Hotez; David Abraham; Sara Lustigman
Journal:  PLoS Negl Trop Dis       Date:  2019-09-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.